Wednesday, February 2, 2011

Cholesterol levels fluctuate during menstrual cycle

National Institutes of Health researchers have shown that women's cholesterol levels correspond with monthly changes in estrogen levels. This natural variation, they suggest, might indicate a need to take into account the phases of a woman's monthly cycle before evaluating her cholesterol measures. On average, the total cholesterol level of the women in the study varied 19 percent over the course of the menstrual cycle. In a typical cycle, estrogen levels steadily increase as the egg cell matures, peaking just before ovulation.

The researchers found that as the level of estrogen rises, high-density lipoprotein (HDL) cholesterol also rises, peaking at the time of ovulation. HDL cholesterol is believed to be protective against heart disease. In contrast, total cholesterol and low-density lipoprotein (LDL) cholesterol levels — as well as another form of blood fat known as triglycerides — declined as estrogen levels rose. The decline was not immediate, beginning a couple of days after the estrogen peak at ovulation. Total cholesterol, LDL cholesterol and triglyceride levels reached their lowest just before menstruation began.

It's more likely cholesterol levels will be elevated in women before ovulation, which could have a particular impact on women whose cholesterol levels are already high. Testing at the end of a woman’s cycle when cholesterol levels are low might do away with the need for an additional test to confirm a high cholesterol reading.

Three new omega-3 studies

Triglycerides
Omega-3 fatty acids, in higher doses, lower triglyceride levels in individuals with moderate hypertriglyceridemia, according to findings in American Journal of Clinical Nutrition. Researchers compared the effects of a lower dose of omega-3 fatty acids (850 mg EPA+DHA daily, as recommended for secondary prevention of coronary heart disease) and a higher dose (3400 mg EPA+DHA daily, indicated for reduction of very high triglycerides) on endothelial function, lipids, and inflammatory markers in subjects with moderately elevated triglycerides who were otherwise healthy. The lower dose of omega-3 fatty acids didn't alter triglyceride levels, but the higher dose reduced triglycerides by 27% compared with placebo.

Heart Failure
New data provides further evidence that n-3 polyunsaturated fatty acids (PUFAs) ma play a role in the treatment of certain patients with heart failure (HF), with investigators showing the omega-3 fatty acids improved echocardiographic measures of systolic and diastolic function and functional capacity in patients with nonischemic cardiomyopathy and minimal symptoms. Compared with patients who received placebo, treatment with a high dose of n-3 PUFAs improved ejection fraction, peak VO2, exercise duration, and mean NYHA functional class, as well as reduced hospitalizations for heart failure. Journal of the American College of Cardiology.

Kidney Stones
Supplementation with n-3 fatty acids can improve urinary risk factors for calcium oxalate stone formation, according to a study in The Journal of Urology. Researchers investigated whether daily dietary supplementation with 900 mg eicosapentaenoic acid (EPA) and 600 mg docosahexaenoic acid (DHA) would influence urinary risk factors for calcium oxalate stone formation under standardized conditions. After 30 days of supplements, urinary oxalate excretion dropped. Similarly, relative supersaturation of calcium oxalate (RS CaOx), a proxy for the risk of calcium oxalate stone formation decreased by 23%.

Steve's Studies: Fresh Heart Health Data

New Tests for Cardiac Risk
A new, highly sensitive investigative blood test may help predict the risk of heart failure and cardiovascular death much earlier than previously possible in older people who do not have symptoms of heart failure. In Journal of the American Medical Association, researchers measured troponin T, a marker for the biological process of cell death that leads to heart failure. The test detects troponin levels that are 10 times lower than previous tests. The researchers found the marker in two-thirds of people without symptoms age 65 or older. They found that the higher the level of troponin, the greater the individual was at risk for symptoms of heart failure or death from cardiovascular disease over the next 10-15 years. The researchers say more study is needed to confirm their findings.

According to new research from American Heart Journal, low serum albumin levels are associated with increased risk for heart failure in the elderly in a time-dependent manner independent of inflammation and incident coronary events.

Bonnie - I see clients with low levels of albumin and many are taking statins without Co-Enzyme Q10. When I tell them they are in danger of heart failure, their doctors dismiss it. This result, while not implicating statins directly, does not explain a cause. I hope now that physicians are not so quick to discount statins as a possible cause. If you have low albumin and you are taking statins, please supplement with CoQ10.


Healthy Fat Good for Cholesterol

The monounsaturated fats found in vegetable oils, nuts and avocados can help boost HDL levels when added to an overall diet that curbs LDL cholesterol, according to a study published in Canadian Medical Association Journal. Half of the participants were randomly assigned to replace 13% of their daily carbohydrates with monounsaturated fats -- in the form of sunflower oil and, if they wanted, avocados. At the end of one month, there was a reduction in LDL cholesterol of about 20%. The total LDL reduction over the two months was 35%, comparable to the benefits that have been seen with cholesterol-lowering statin drugs. The monounsaturated-fat group also showed an average increase in HDL cholesterol of about 12%, as well as a reduction in levels of C-reactive protein, a marker of inflammation in the blood vessels that has been associated with heart disease risk.

CBT Helpful for Those With CHD
In patients with coronary heart disease, cognitive behavioral therapy (CBT) appears to be associated with lower rates of recurrent acute myocardial infarctions (AMIs) and coronary heart disease events, according to new research in the Archives of Internal Medicine. Psychosocial factors have been shown to account for approximately 30% of the attributable risk of acute myocardial infarction. Emotional factors include anxiety, depression, anger, and hostility, whereas chronic stressors include social support, work or marital stressors, and socioeconomic status. Of the patients, the reference group received traditional care, whereas the intervention group received traditional care and CBT. CBT consisted of 20 two-hour sessions during a year's time where participants learned different methods to manage and reduce stress. Mean follow-up time was 94 months. Use of CBT was associated with lower rates of recurrent and nonfatal and fatal recurrent coronary heart disease events.

The Importance of CRP in Post-Menopausal Women
This Journal Menopause study examined C-reactive protein (CRP) levels predicting cardiovascular events (CVEs) among hormone therapy (HT) users and nonusers. CRP levels are higher in women who use oral HT than those in nonusers. However, CVE risk increased with increased CRP for both HT users and nonusers (HT users slightly higher). In conclusion, the researchers stated that CRP predicts CVE among both HT users and nonusers at levels of 3 mg/L or higher.

Dark Chocolate To the Rescue
31,823 middle-aged and elderly Swedish women who regularly ate a small amount of chocolate had lower risks of heart failure risks, in a study reported in Circulation: Heart Failure. The quality of chocolate consumed by the women had a higher density cocoa content (70% or more). Women who ate an average of one to two servings of the high-quality chocolate per week had a 32 percent lower risk of developing heart failure. Those who had one to three servings per month had a 26 percent lower risk.

Wednesday, January 26, 2011

Very low saturated fat intake a no-no

Very low intakes of saturated fats may be just as bad for you as very high intakes, and could lead to an increased risk of death from stroke - according to a study published by the American Journal of Clinical Nutrition. SFA intake was inversely associated with mortality from stroke. This inverse association was similarly observed for intraparenchymal hemorrhage and ischemic stroke.

Ischemic stroke is considered to be an atherosclerotic disease in Western societies; however research suggests that other pathways, like arteriosclerosis, may also be implicated in ischemic stroke. The aim of the new research was to test the associations between SFA intake and the risks of cardiovascular disease mortality in 110,000 Japanese subjects.

Surprisingly the population study also observed that decreasing SFA intake by increasing polyunsaturated fatty acids (PUFA) was “significantly positively associated with stroke mortality.”

The lowest incidence of stroke mortality was observed in people with moderate SFA intake of between 18 and 40g per day. Reducing SFA intake to below 18g was seen to increase the relative risk of stroke by nearly 20 per cent, and intake of less than 11g of per day was associated with an increased risk of almost 66 per cent.

In discussing their results, the researchers speculate that saturated fats could have different impacts in larger arteries compared to small vessels - suggesting that although in larger vessels saturated fats can increase the risks of atherosclerotic plaques, but in smaller vessels low SFA levels could lead to angionecrosis through a reduction of smooth muscles cells and increased fragility of vascular walls.

Bonnie - we have always said that you do not need to eliminate saturated fats fro your diet. You need saturated fat. You just have to consume in moderate amounts. Replacing with polyunsaturated oils (most likely omega-6 vegetable oils) can increase stroke risk. If an imbalance between omega-6 and omega-9 occurs, inflammation often follows.

Acetominophen use not a good choice for adolescents

Acetaminophen use in adolescents is linked to development and/or maintenance of asthma, rhinoconjunctivitis, and eczema, according to the results of a study in the American Journal of Respiratory and Critical Care Medicine. The study has identified that the reported use of acetaminophen in 322,959 13- and 14-year-old adolescent children was associated with an exposure-dependent increased risk of asthma symptoms

The overall population attributable risks for current symptoms of severe asthma were around 40 percent, suggesting that if the associations were causal, they would be of major public health significance. Randomized controlled trials are now urgently required to investigate this relationship further and to guide the use of antipyretics, not only in children but in pregnancy and adult life.

There was also an acetaminophen exposure–dependent increased risk for current symptoms of rhinoconjunctivitis and eczema.

Wednesday, January 19, 2011

Alpha Lipoic Acid shows promise for obesity prevention

Alpha-lipoic acid (ALA) is “an ideal antioxidant candidate" for treating obesity-related diseases, according to a recent study from Current Pharmaceutical Design. Researchers found ALA reduced weight, body mass index (BMI), blood pressure and waist size after four months of supplementation. To investigate the beneficial effects of ALA in pre-obese and obese subjects, researchers added ALA to the diets of 1,127 subjects. According to BMI, 53 percent of the participants were obese and 43 percent were pre-obese. For four months, each subject received a daily supplement of 800 mg of ALA. In pre-obese subject, the researchers reported a significant reduction in weight (8 percent for both men and women), BMI (2 points on average), blood pressure and abdominal circumference. Obese subjects also experienced significant reductions in these parameters.

Green Tea: 4 cups or supplement extract for positive weight reduction

According to a recent study in the Journal of the American College of Nutrition, green tea beverage consumption (4 cups) or supplementation of 450 mg. green tea extract daily for eight weeks significantly decreased body weight and BMI in 35 subjects with obesity and metabolic syndrome.